Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
CSL Ltd
CSLCurrent price
301.84 AUD
+0.18 AUD (+0.06%)
Last closed
301.66 AUD
Company
www.csl.com.au
ISIN
AU000000CSL8
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
144 618 629 279 AUD
Yield for 12 month
+13.61 %
1Y
3Y
5Y
10Y
15Y
CSL
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Address: 655 Elizabeth Street, Melbourne, VIC, Australia, 3000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
485.57 AUDP/E ratio
36.5335Dividend Yield
1.33 %Current Year
+33 257 850 405 AUD
Last Year
+29 055 906 477 AUD
Current Quarter
+15 046 291 032 AUD
Last Quarter
+18 224 150 116 AUD
Current Year
+16 189 713 292 AUD
Last Year
+14 042 732 392 AUD
Current Quarter
+6 852 543 032 AUD
Last Quarter
+9 347 408 750 AUD
Key Figures CSL
1 year
3 years
5 years
10 years
EBITDA
4 598 462 980 AUD
Operating Margin TTM
PE Ratio
36.5335
Return On Assets TTM
6.56 %
PEG Ratio
–
Return On Equity TTM
14.58 %
Wall Street Target Price
485.57 AUD
Revenue TTM
14 737 387 179 AUD
Book Value
35.78 AUD
Revenue Per Share TTM
Dividend Share
2.63 AUD
Quarterly Revenue Growth YOY
10.1 %
Dividend Yield
1.33 %
Gross Profit TTM
6 815 045 801 AUD
Earnings per share
8.18 AUD
Diluted Eps TTM
8.18 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
30.7 %
Profit Margin
17.85 %
Dividend Analytics CSL
Dividend growth over 5 years
59 %Continuous growth
3 yearsPayout Ratio 5 years average
67 %Dividend History CSL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
4
Ex Dividend Date
09.09.2024
Forward Annual Dividend Yield
1.33 %
Last Split Factor
3:1
Payout Ratio
45.18 %
Last Split Date
18.10.2007
Dividend Date
–
Stock Valuation CSL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
36.5335
Forward PE
35.461
Enterprise Value Revenue
7.3209
Price Sales TTM
9.8235
Enterprise Value EBITDA
22.722
Price Book MRQ
5.5876
Financials CSL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CSL
For 52 weeks
224.63 AUD
309.99 AUD
50 Day MA
304.32 AUD
Shares Short Prior Month
–
200 Day MA
288.54 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart